De Luca Angela, Ruggiero Roberta, Cordaro Aurora, Marrelli Benedetta, Raimondi Lavinia, Costa Viviana, Bellavia Daniele, Aiello Elisabetta, Pavarini Matteo, Piccininni Antonio, Tatullo Marco, Boanini Elisa, Paduano Francesco, Giavaresi Gianluca
CS-Surgical Sciences and Technologies-SS Omics Science Platform for Personalized Orthopedics, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.
Stem Cells and Medical Genetics Units, Biomedical Section, Tecnologica Research Institute and Marrelli Health, 88900 Crotone, Italy.
J Funct Biomater. 2024 Dec 18;15(12):382. doi: 10.3390/jfb15120382.
Magnesium and its alloys represent promising candidates for biomedical implants due to their biodegradability and mechanical properties, which are similar to natural bone. However, their rapid degradation process characterized by dynamic pH fluctuations and significant hydrogen gas evolution during biocorrosion adversely affects both in vitro and in vivo assessments. While the ISO 10993-5 and 12 standards provide guidelines for evaluating the in vitro biocompatibility of biodegradable materials, they also introduce testing variability conditions that yield inconsistent results. To address these inherent characteristics of Mg alloys, developing improved methods that accurately simulate the physiological environment for in vitro biocompatibility testing is essential. This study introduces two novel extraction approaches for evaluating Mg alloys: a buffered solution utilizing PBS/DMEM with quaternary dilutions and a modified ISO standard protocol employing decuple dilution of conventional unbuffered extracts. The present findings establish that controlled optimization of extraction conditions, specifically buffer composition and dilution parameters, enables reliable in vitro cytotoxicity assessment of Mg alloys, providing a robust methodology that advances the preclinical evaluation of these promising biodegradable materials.
镁及其合金因其生物可降解性和与天然骨骼相似的机械性能,成为生物医学植入物的理想候选材料。然而,它们在生物腐蚀过程中的快速降解过程,其特征是动态pH波动和大量氢气释放,对体外和体内评估均产生不利影响。虽然ISO 10993-5和12标准为评估可生物降解材料的体外生物相容性提供了指导方针,但它们也引入了导致结果不一致的测试可变条件。为了解决镁合金的这些固有特性,开发能够准确模拟体外生物相容性测试生理环境的改进方法至关重要。本研究介绍了两种评估镁合金的新型提取方法:一种是使用PBS/DMEM进行四级稀释的缓冲溶液,另一种是采用传统非缓冲提取物十倍稀释的改良ISO标准方案。目前的研究结果表明,通过对提取条件进行可控优化,特别是缓冲液组成和稀释参数,能够对镁合金进行可靠的体外细胞毒性评估,提供了一种强大的方法,推进了对这些有前景的可生物降解材料的临床前评估。